Introduction: Fine-needle aspiration cytology (FNAC) is a simple, minimally invasive, and effective tool that can be used to accurately diagnose benign and malignant lesions of the breast. The International Academy of Cytologists Yokohama system and Modified Masood’s Scoring Index (MMSI) are two important systems to categorize palpable breast lesions on FNAC. The goal of the present study was to evaluate the IAC Yokohama system and MMSI in the cytological diagnosis and classification of diverse breast lesions and to compare the diagnostic accuracy of both systems through cyto-histological correlation. Methods: A retrospective cross-sectional study was done within the 3-year period from 2019 to 2021. Seven hundred and ninety cases of FNAC breast lesions were included and were categorized following the recommendations by the International Academy of Cytologists Yokohama system and MMSI. The sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy for both systems were calculated, taking histopathology as the standard. Additionally, the risk of malignancy (ROM) of each category was calculated in the Yokohama system. Results: The IAC Yokohama system’s sensitivity, specificity, PPV, NPV, and diagnostic accuracy were 96.8, 95.8%, 96%, 96.6%, and 96.3%. The MMSI had sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 95.8%, 98.4%, 98.3%, 96.1%, and 97.1%, respectively. The ROM for insufficient, benign, atypical, suspicious for malignancy, and malignant categories were 12.5%, 1.8%, 20%, 90.4%, and 97.5%, respectively. Conclusion: The categorization of breast lumps using the MMSI is more accurate and more specific in diagnosing malignant cases, and thus, the MMSI system is more precise and accurate at diagnosing malignant cases.

1.
Breast cancer [Internet]. Who.int. 2022 [cited 22 July 2022]. Available from: https://www.who.int/news-room/fact-sheets/detail/breast-cancer.
2.
[Internet]. Gco.iarc.fr. 2022 [cited 20 July 2022]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf.
3.
Apuroopa M, Chakravarthy VK, Rao DR. Application of Yokohama system for reporting breast fine needle aspiration cytology in correlation with histopathological and radiological findings. Annals Pathology Lab Med. 2020;7(4):A210–215.
4.
Wang M, He X, Chang Y, Sun G, Thabane L. A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: a systematic review and meta-analysis. Breast. 2017;31:157–66.
5.
Field A, Raymond W, Schmitt F. The international academy of cytology Yokohama system for reporting breast fine needle aspiration biopsy cytopathology. Acta Cytologica. 2019;63(4):255–6.
6.
Field AS, Raymond WA, Schmitt F. The international academy of cytology Yokohama system for reporting breast fine needle aspiration biopsy cytopathology: recent research findings and the future. Cancer Cytopathol. 2021;129(11):847–51.
7.
Masood S, Frykberg ER, McLellan GL, Scala- pino MC, Mitchum DG, Bullard JB. Prospective evaluation of radiologically directed fine- needle aspiration biopsy of nonpalpable breast lesions. Cancer. 1990 Oct;66(7):1480–7.
8.
Nandini N, Manjunath G, Rekha T. Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature. Indian J Cancer. 2011;48(2):240.
9.
Wu Q, Siddharth S, Sharma D. Triple negative breast cancer: a mountain yet to be scaled despite the triumphs. Cancers. 2021;13(15):3697.
10.
Karim M, Khan K, Khan A, Javed A, Fazid S, Aslam M. Triple assessment of breast lump: should we perform core biopsy for every patient? Cureus. 2020;12(3):e7479.
11.
Beca F, Schmitt F. Ancillary tests in breast cytology: a practical guide. Acta Cytologica. 2019;63(4):302–13.
12.
Montezuma D, Malheiros D, Schmitt F. Breast fine needle aspiration biopsy cytology using the newly proposed IAC Yokohama system for reporting breast cytopathology: the experience of a single institution. Acta Cytologica. 2019;63(4):274–9.
13.
Ahuja S, Malviya A. Categorization of breast fine needle aspirates using the international academy of cytology Yokohama system along with assessment of risk of malignancy and diagnostic accuracy in a tertiary care centre. J Cytol. 2021;38(3):158.
14.
Wong S, Rickard M, Earls P, Arnold L, Bako B, Field AS. The international academy of cytology Yokohama system for reporting breast fine needle aspiration biopsy cytopathology: a single institutional retrospective study of the application of the system categories and the impact of rapid onsite evaluation. Acta Cytologica. 2019;63(4):280–91.
15.
Shivamurthy A, Jaiprakash P, Vasudevan G, Kudva R, Valiathan M. Pitfalls in cytological diagnosis of mucinous carcinomas of breast. Indian J Pathol Oncol. 2021;8(1):100–3.
16.
Marabi M, Aphivatanasiri C, Jamidi SK, Wang C, Li JJ, Hung EH. The international academy of cytology Yokohama system for reporting breast cytopathology showed improved diagnostic accuracy. Cancer Cytopathol. 2021;129(11):852–64.
17.
Shabb NS, Boulos FI, Abdul-Karim FW. Indeterminate and erroneous fine-needle aspirates of breast with focus on the ‘True Gray Zone’: a review. Acta Cytologica. 2013;57(4):316–31.
18.
Tse GMK, Ma TKF, Lui PCW, Ng DCH, Yu AMC, Vong JSL. Fine needle aspiration cytology of papillary lesions of the breast: how accurate is the diagnosis? J Clin Pathol. 2008;61(8):945–9.
19.
Cherath SK, Chithrabhanu SM. Evaluation of masood’s and modified Masood’s scoring systems in the cytological diagnosis of palpable breast lump aspirates. J Clin Diagn Res. 2017;11(4):EC06–10.
20.
D’Arcy C, Quinn C. Apocrine lesions of the breast: part 1 of a two-part review: benign, atypical and in situ apocrine proliferations of the breast. J Clin Pathol. 2018;72(1):1–6.
You do not currently have access to this content.